Banco Bilbao Vizcaya Argentaria S.A. trimmed its stake in DocuSign, Inc. (NASDAQ:DOCU - Free Report) by 8.0% in the fourth quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The fund owned 37,437 shares of the company's stock after selling 3,270 shares during the quarter. Banco Bilbao Vizcaya Argentaria S.A.'s holdings in DocuSign were worth $3,393,000 at the end of the most recent quarter.
A number of other institutional investors also recently made changes to their positions in the stock. Kestra Investment Management LLC acquired a new position in shares of DocuSign during the fourth quarter worth about $30,000. First Horizon Advisors Inc. raised its holdings in shares of DocuSign by 102.6% during the 4th quarter. First Horizon Advisors Inc. now owns 397 shares of the company's stock valued at $36,000 after buying an additional 201 shares during the period. Modus Advisors LLC acquired a new position in DocuSign during the 4th quarter worth approximately $36,000. Bessemer Group Inc. boosted its holdings in DocuSign by 490.0% in the 4th quarter. Bessemer Group Inc. now owns 472 shares of the company's stock worth $42,000 after acquiring an additional 392 shares during the period. Finally, Avion Wealth grew its position in DocuSign by 309.2% in the fourth quarter. Avion Wealth now owns 487 shares of the company's stock valued at $43,000 after acquiring an additional 368 shares in the last quarter. 77.64% of the stock is owned by institutional investors and hedge funds.
Insider Buying and Selling at DocuSign
In other news, CFO Blake Jeffrey Grayson sold 8,000 shares of the business's stock in a transaction on Friday, February 14th. The shares were sold at an average price of $86.90, for a total value of $695,200.00. Following the completion of the sale, the chief financial officer now directly owns 77,851 shares in the company, valued at approximately $6,765,251.90. The trade was a 9.32 % decrease in their ownership of the stock. The sale was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. Also, insider Robert Chatwani sold 15,706 shares of the firm's stock in a transaction dated Wednesday, March 19th. The shares were sold at an average price of $83.19, for a total value of $1,306,582.14. Following the completion of the sale, the insider now directly owns 76,842 shares in the company, valued at approximately $6,392,485.98. This represents a 16.97 % decrease in their ownership of the stock. The disclosure for this sale can be found here. In the last quarter, insiders have sold 55,851 shares of company stock worth $4,607,439. 1.66% of the stock is currently owned by company insiders.
Wall Street Analyst Weigh In
A number of equities analysts have weighed in on DOCU shares. William Blair reissued an "outperform" rating on shares of DocuSign in a research report on Monday, April 21st. Robert W. Baird set a $93.00 price target on DocuSign in a report on Friday, March 14th. UBS Group dropped their price objective on DocuSign from $90.00 to $85.00 and set a "neutral" rating on the stock in a report on Thursday, April 17th. Citigroup increased their target price on DocuSign from $113.00 to $115.00 and gave the company a "buy" rating in a research note on Friday, March 14th. Finally, Bank of America dropped their price target on shares of DocuSign from $112.00 to $98.00 and set a "neutral" rating for the company in a research note on Friday, March 14th. One research analyst has rated the stock with a sell rating, eleven have given a hold rating and four have assigned a buy rating to the company. Based on data from MarketBeat, the company presently has a consensus rating of "Hold" and a consensus price target of $92.46.
Check Out Our Latest Report on DocuSign
DocuSign Trading Down 0.6 %
NASDAQ:DOCU traded down $0.52 during trading hours on Wednesday, hitting $81.75. 1,754,039 shares of the stock traded hands, compared to its average volume of 2,738,269. The firm has a 50 day moving average price of $80.17 and a 200 day moving average price of $83.86. The firm has a market cap of $16.55 billion, a price-to-earnings ratio of 16.86, a PEG ratio of 6.94 and a beta of 1.20. DocuSign, Inc. has a fifty-two week low of $48.70 and a fifty-two week high of $107.86.
DocuSign (NASDAQ:DOCU - Get Free Report) last announced its quarterly earnings data on Thursday, March 13th. The company reported $0.86 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.84 by $0.02. The firm had revenue of $776.25 million during the quarter, compared to the consensus estimate of $760.94 million. DocuSign had a return on equity of 14.90% and a net margin of 34.73%. The business's revenue for the quarter was up 9.0% on a year-over-year basis. During the same period in the prior year, the business earned $0.76 EPS. Research analysts predict that DocuSign, Inc. will post 1.17 EPS for the current year.
DocuSign Company Profile
(
Free Report)
DocuSign, Inc provides electronic signature solution in the United States and internationally. The company provides e-signature solution that enables sending and signing of agreements on various devices; Contract Lifecycle Management (CLM), which automates workflows across the entire agreement process; Document Generation streamlines the process of generating new, custom agreements; and Gen for Salesforce, which allows sales representatives to automatically generate agreements with a few clicks from within Salesforce.
Featured Articles

Before you consider DocuSign, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and DocuSign wasn't on the list.
While DocuSign currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
MarketBeat just released its list of 10 cheap stocks that have been overlooked by the market and may be seriously undervalued. Enter your email address and below to see which companies made the list.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.